Technician Advanced Training Point-of-Care Testing /Test & Treat On-Demand 4h PTCB Approved

Now more than ever, pharmacies are considered a place for front-line delivery of healthcare. This 4-hour training will equip you with the necessary skills to administer point of care tests in the pharmacy. Don’t miss the opportunity to assist pharmacists with testing services for your pharmacy’s patients.

Be prepared by taking this course that includes:

  • Compliance requirements, including how to obtain a CLIA waiver 
  • Procedures for PPE, specimen collecting, and devices to use
  • How to conduct tests for diabetes and hyperlipidemia 
  • How to administer tests for COVID-19, Influenza, HIV, Hepatitis C, and Group A Strep
  • Documentation of hands-on specimen collection technique, specific to your pharmacy’s operations

Learning Objectives

Upon completion of the full course, pharmacy technicians should be able to:
1. Describe current trends in pharmacy practice and point of care testing (POCT).
2. List the pros/cons of implementing point of care testing.
3. Identify the role pharmacists and pharmacy technicians can play in providing point of care testing services.
4. Describe the process to obtain a clinical laboratory improvement amendment (CLIA) waiver license.
5. List appropriate follow-up actions needed after conducting point of care testing (both internal and external).
6. Review the Centers for Disease Control and Prevention Self-Assessment Checklist for Good Testing Practice.
7. Find CLIA resources and locate forms to assist in standardizing the point of care testing process.
8. Review personal protective equipment (PPE) requirements for various POCTs.
9. Compare and contrast the devices needed to administer an appropriate POCT.
10. Collect specimen for diagnostic testing through nasal, throat, or blood routes.
11. Describe patient characteristics for an individual at risk for diabetes and/or hyperlipidemia or who might benefit from a wellness screening.
12. Describe patient characteristics for an individual at risk for infectious disease, including HIV, Hepatitis C, Group A Streptococcus, Influenza, and COVID-19.

Faculty

Joshua Davis Kinsey, PharmD

VP, Education
CEimpact

Disclosures:

Joshua Davis Kinsey has no relevant financial relationships with ineligible companies to disclose.

Elizabeth Skoy, PharmD

Professor
North Dakota State University 

Disclosures:

Elizabeth Skoy has no relevant financial relationships with ineligible companies to disclose.

Brett Barker, PharmD

Disclosures:

Brett Barker reports that he is an employee of Nucara. All relevant financial relationships have been mitigated.

Anthony J. Bolus, PharmD, RPh

Disclosures:

Anthony J. Bolus has no relevant financial relationships with ineligible companies to disclose.

Julie Breuer

PharmD Candidate
University of Iowa

Disclosures:

Julie Breuer has no relevant financial relationships with ineligible companies to disclose.

Patrick Devereux, PharmD, RPh

Disclosures:

Patrick Devereux has no relevant financial relationships with ineligible companies to disclose.

Alex Evans, PharmD, MBA

Disclosures:

Alex Evans has no relevant financial relationships with ineligible companies to disclose.

Michele Fountain, PharmD

Disclosures:

Michele Fountain has no relevant financial relationships with ineligible companies to disclose.

John A. Galdo, PharmD, MBA, BCPS, BCGP

Consultant, CEimpact
Pharmacist, Ross Bridge Pharmacy
CEO, Seguridad, Inc 

Disclosures:

John Galdo reports that he is CEO of Seguridad and his spouse works for Eli Lilly and was an employee of Prime Therapeutics. All relevant financial relationships have been mitigated.

David Hachey, PharmD, AAHIVP

Disclosures:

David Hachey has no relevant financial relationships with ineligible companies to disclose.

Monica Nikseresht

PharmD Candidate
Drake University

Disclosures:

Monica Nikseresht has no relevant financial relationships with ineligible companies to disclose.

Alexis Page, PharmD

Disclosures:

Alexis Page has no relevant financial relationships with ineligible companies to disclose.

Kathryn Schott, PhD

Vice President - Education Services
CEimpact

Disclosures:

Kathryn Schott has no relevant financial relationships with ineligible companies to disclose.

Course Details